Laparoscopic Roux
10.11817/j.issn.1672-7347.2021.190806
- Author:
Weizheng LI
1
;
Zhaomei YU
2
;
Liyong ZHU
3
;
Pengzhou LI
2
;
Xiangwu YANG
2
;
Shaihong ZHU
4
Author Information
1. Department of General Surgery, Third Xiangya Hospital, Central South University, Changsha 410013, China. zhnfy-Daniel@csu.edu.cn.
2. Department of General Surgery, Third Xiangya Hospital, Central South University, Changsha 410013, China.
3. Department of General Surgery, Third Xiangya Hospital, Central South University, Changsha 410013, China. zly8128@126.com.
4. Department of General Surgery, Third Xiangya Hospital, Central South University, Changsha 410013, China. shaihongzhu@126.com.
- Publication Type:Journal Article
- Keywords:
Type 2 diabetes mellitus;
body mass index;
gastrointestinal stromal tumor;
laparoscopic Roux-en-Y gastric bypass
- MeSH:
Body Mass Index;
China;
Diabetes Mellitus, Type 2/complications*;
Gastric Bypass;
Humans;
Laparoscopy;
Male;
Neoplasm Recurrence, Local;
Treatment Outcome
- From:
Journal of Central South University(Medical Sciences)
2021;46(1):98-103
- CountryChina
- Language:English
-
Abstract:
Laparoscopic Roux-en-Y gastric bypass (LRYGB) has been proved to be a safe and effective treatment for Type 2 diabetes mellitus (T2DM) patients with body mass index (BMI) >27.5 kg/m
